Intelligent bio solutions inc. announces closing of $4.378 million underwritten public offering including partial exercise of underwriters' overallotment option

New york, oct. 04, 2023 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its previously announced underwritten public offering of units (the “units”) for gross proceeds of approximately $4.378 million prior to deducting underwriting discounts and commissions and offering expenses, including partial exercise of the underwriter's over-allotment option to purchase additional shares of common stock and warrants.
INBS Ratings Summary
INBS Quant Ranking